Gilead Sciences has made another foray into the natural killer (NK) cell category, paying $300 million upfront to access Dragonfly Therapeutics' TriNKET platform to find therapies for cancer and ...

About Dragonfly Energy Holdings Corp. Dragonfly Energy Holdings Corp. engages in the manufacture and supply of deep cycle lithium-ion batteries. It also focuses on delivering an energy storage ...

Bristol-Myers Squibb has signed an agreement worth $475 million to develop a new form of cancer immunotherapy drug with US biotech Dragonfly Therapeutics. BMS is best known as an early pioneer of ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...

As of October 31, 2025, Dragonfly Energy Holdings Corp. had a $149.8 million market capitalization, putting it in the 26th percentile of companies in the Electrical Equipment industry. Dragonfly ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

Andrew J. Stillman is a freelance writer and yoga instructor exploring the world. Check him out at andrewjstillman.com or follow him @andrewjstillman on all the things.